Drug profile · INN
ranitidine bismuth citrate
TRITEC
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ranitidine bismuth citrate (TRITEC) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN ranitidine bismuth citrate
Brand TRITEC
Route ORAL
Formulation TABLET
Frequently asked questions
What is ranitidine bismuth citrate?
ranitidine bismuth citrate (TRITEC) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ranitidine bismuth citrate?
TRITEC is a marketed brand name for ranitidine bismuth citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ranitidine bismuth citrate?
ranitidine bismuth citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.